Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |